Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20060111744 A1
Publication typeApplication
Application numberUS 11/163,152
Publication dateMay 25, 2006
Filing dateOct 6, 2005
Priority dateOct 13, 2004
Also published asUS8282554, US8333700, US8523775, US8932224, US20120197120, US20120330222, US20120330223, US20130310863, US20150100075
Publication number11163152, 163152, US 2006/0111744 A1, US 2006/111744 A1, US 20060111744 A1, US 20060111744A1, US 2006111744 A1, US 2006111744A1, US-A1-20060111744, US-A1-2006111744, US2006/0111744A1, US2006/111744A1, US20060111744 A1, US20060111744A1, US2006111744 A1, US2006111744A1
InventorsInder Raj Makin, Peter Barthe, Michael Slayton
Original AssigneeGuided Therapy Systems, L.L.C.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Method and system for treatment of sweat glands
US 20060111744 A1
Abstract
A method and system for ultrasound treatment of sweat glands are provided. An exemplary method and system for targeted treatment of sweat glands can be configured in various manners, such as through use of therapy only, therapy and monitoring, imaging and therapy, or therapy, imaging, and monitoring, and/or through use of focused, unfocused, or defocused ultrasound through control of various spatial and temporal parameters. As a result, ablative energy can be deposited at the particular depth at which the aberrant sweat gland population is located below the skin surface.
Images(20)
Previous page
Next page
Claims(22)
1. An ultrasound treatment system configured for treatment of sweat glands, said ultrasound treatment system comprising:
a control system for facilitating control of the ultrasound treatment system; and
a probe system configured for targeted delivery of ultrasound energy to produce a treatment region for destroying said sweat gland.
2. The ultrasound treatment system according to claim 1, wherein said probe system is configured for destroying the sweat gland within a specified treatment depth identified through localization of said sweat gland.
3. The ultrasound treatment system according to claim 1, wherein said spatially defined patterns comprise a discrete locus of spaced lesions comprising at least one of cross-stitch, cigar-shaped, ellipsoidal, mushroom-shaped and wedge-shaped lesions.
4. The ultrasound treatment system of claim 1, wherein said control system comprises an imaging system configured for monitoring of said treatment region prior to, during and after delivery of ultrasound energy into said sweat gland.
5. The ultrasound treatment system of claim 4, wherein said imaging system is configured to provide feedback to facilitate said targeted delivery.
6. The ultrasound treatment system according to claim 1, wherein said display system comprises a display of images corresponding to a temperature profile of said treatment region.
7. The ultrasound treatment system according to claim 1, wherein said probe system comprises an imaging and therapy transducer configured for targeted delivery of ablative ultrasound within said sweat gland.
8. The ultrasound treatment system according to claim 7, wherein said imaging and therapy transducer comprise a combined transducer within an electronic array of transduction elements.
9. The ultrasound treatment system according to claim 7, wherein said imaging and therapy transducer comprises a single element array comprising a single transduction element and a plurality of masks configured for generating a plurality of ablative zones with each of said plurality of ablative zones providing at least one of focused, defocused and planar ultrasound energy distribution.
10. The ultrasound treatment system according to claim 1, wherein said probe is configured for targeted delivery of ultrasound energy through adjustable control of spatial parameters and temporal parameters of said probe to generate conformal lesions of specifically targeted shapes, sizes and orientations.
11. The ultrasound treatment system according to claim 1, wherein said treatment system comprises an imaging, therapy, and treatment monitoring system combined with auxiliary imaging and treatment monitoring apparatus and secondary therapy systems, and wherein said auxiliary imaging apparatus comprises at least one of a photographic instrument and an optical modality.
12. The ultrasound treatment system according to claim 1, wherein said control system comprises an imaging system configured for facilitating at least one of one-dimensional, two-dimensional and three-dimensional imaging or therapy.
13. A method for providing treatment of acne and sweat glands, said method comprising:
localizing of at least one targeted region within a region of interest, said localizing configured for identifying at least one sweat gland;
targeting of delivery of ablative ultrasound energy from a transducer probe to said at least one sweat gland; and
monitoring of results of said targeted delivery within said at least one sweat gland during and after said targeted delivery to continue planning of treatment.
14. The method of claim 13, wherein said localizing comprises imaging a region of interest to identify said at least one sweat gland.
15. The method of claim 13, said targeting of delivery of ultrasound energy comprises destroying said sweat gland within a specified treatment depth identified through localization of said sweat gland.
16. The method of claim 13, wherein said targeting of delivery comprises adjustable control of spatial parameters and temporal parameters of said transducer probe to generate conformal lesions of specifically targeted shapes, sizes and orientations.
17. The method of claim 13, wherein said monitoring of results comprises measurement of results of treatment of said at least one sweat gland as visualized during and after said target delivery of ablative ultrasound.
18. The method of claim 13, wherein said monitoring comprises monitoring the temperature profile of said targeted region.
19. The method of claim 13, wherein said targeted delivery comprises producing of a matrix of spaced treatment spots comprising at least one of two-dimensional and three-dimensional matrix of lesions along a scanned pattern created by scanning of said transducer probe.
20. The method according to claim 19, wherein producing said spatially defined patterns comprises producing a discrete locus of spaced conformal lesions based on control of spatial and temporal parameters.
21. The method according to claim 13, wherein said localizing comprises generating three-dimensional imaging information and said targeting comprises treating three-dimensional treatment region.
22. The method according to claim 13, wherein said targeting of delivery further comprises cooling through any tissue regions between and including skin and said at least one sweat gland to facilitate treatment.
Description
    CROSS-REFERENCE TO RELATED APPLICATIONS
  • [0001]
    Application claims priority to and benefit of U.S. Provisional Application No. 60/61 7,752, entitled “Method and System for Treatment of Sweat Glands”, and filed on Oct. 6, 2004.
  • FIELD OF INVENTION
  • [0002]
    This invention generally relates to a therapeutic ultrasound method and system, and more particularly, to a method and system for ultrasound treatment for superficial tissue containing sweat glands.
  • BACKGROUND OF INVENTION
  • [0003]
    The sweat glands in the body are of divided into apocrine and eccrine glands. Apocrine glands are similar to sebaceous glands, and are present mainly in the axillae. These glands, like sebaceous glands, secrete an oily proteinaceous product into the follicles. Bacterial digestion of apocrine sweat is largely responsible for underarm “body odor”. Similarly, eccrine sweat glands are present deep in the dermis in the palms, soles and armpits and are responsible for temperature regulation resulting from sweating. Excessive activity of these glands also results in copious amounts of abnormal sweating (“hyperhidrosis”), primarily under autonomic neuronal control. Reduction of sweating from under the armpits and other regions is a particularly desirable effect within the modern society. Presently, chemical antiperspirants and deodorants are used frequently as a matter of personal hygiene. Antiperspirants are aluminum based salts that block the sweat gland ducts. The deodorant changes the pH of the skin milieu thereby minimizing the presence of (smell inducing) bacteria. The effects with both these components however, are temporary and these chemicals are known to irritate the skin in a good percentage of users.
  • [0004]
    Further, there is currently a significant unmet need in managing the excessive sweating and concomitant issues with odor as a result of Hydradenitis suppurativa (irritable infected armpit). This acne-like process in apocine follicles also causes hydradenitis suppurativa, which is often a devastating condition in which very painful cysts and scarring occurs repeatedly in the axillae. The etiology (causes) of this clinical condition is not well understood. However, there are a number of marginally effective approaches to manage this condition. Retinoid drug therapy works marginally but is associated with severe toxicity. Some prescription formulations of antiperspirants can be used, but they are not particularly effective. These preparations can be applied with the addition of an iontophoretic device. This technique however, is not known to be any more effective than the formulation. The sweat glands can be surgically removed from the armpits and/or the sympathetic nerve supply can be interrupted surgically. This approach is fraught with its own drawbacks in terms of morbidity, scarring and cost. BOTOX® is being used ever more for paralyzing the nerve connections that induce excessive sweating in the armpits. However, this is a new approach yet to be completely validated. This technique requires multiple injections (painful) and the results last a few months only (3-4 months), hence need to be repeated. This technique does not get rid of the odor associated with the condition.
  • SUMMARY OF INVENTION
  • [0005]
    The present invention describes a non-invasive method and system for using therapeutic ultrasound energy for the treatment of conditions resulting from sweat gland disorders. An ultrasound system and method comprises a transducer probe and control system configured to deliver ultrasound energy to the regions of the superficial tissue (e.g., skin) such that the energy can be deposited at the particular depth at which the aberrant sweat gland population is located below the skin surface.
  • [0006]
    In accordance with various exemplary embodiments, the ultrasound transducer can be driven at a number of different frequency regimes such that the depth and shape of energy concentration can match the region of treatment. In addition, the ultrasound source or beam radiated from the transducer can be highly focused, weakly focused, or divergent, each in a cylindrical or spherical geometric configuration, and/or can also be planar to radiate a directive beam through the tissue, or various other configurations. Further, the ultrasound field can be varied spatially and temporally in a suitable manner to achieve the optimal tissue effect and/or type of conformal lesion for treating the sweat glands.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0007]
    The subject matter of the invention is particularly pointed out in the concluding portion of the specification. The invention, however, both as to organization and method of operation, may best be understood by reference to the following description taken in conjunction with the accompanying drawing figures, in which like parts may be referred to by like numerals:
  • [0008]
    FIG. 1 illustrates a block diagram of an ultrasound therapy system for treating sweat glands in accordance with an exemplary embodiment of the present invention;
  • [0009]
    FIG. 2A-2E illustrates schematic diagrams of ultrasound treatment systems configured to treat the sweat glands via direct targeting of heating and damage within the treatment layer in accordance with various exemplary embodiments of the present invention;
  • [0010]
    FIGS. 3A and 3B illustrate block diagrams of an exemplary control system in accordance with exemplary embodiments of the present invention;
  • [0011]
    FIGS. 4A and 4B illustrate block diagrams of an exemplary probe system in accordance with exemplary embodiments of the present invention;
  • [0012]
    FIG. 5 illustrates a cross-sectional diagram of an exemplary transducer in accordance with an exemplary embodiment of the present invention;
  • [0013]
    FIGS. 6A and 6B illustrate cross-sectional diagrams of an exemplary transducer in accordance with exemplary embodiments of the present invention;
  • [0014]
    FIG. 7 illustrates exemplary transducer configurations for ultrasound treatment in accordance with various exemplary embodiments of the present invention;
  • [0015]
    FIGS. 8A and 8B illustrate cross-sectional diagrams of an exemplary transducer in accordance with another exemplary embodiment of the present invention;
  • [0016]
    FIG. 9 illustrates an exemplary transducer configured as a two-dimensional array for ultrasound treatment in accordance with an exemplary embodiment of the present invention;
  • [0017]
    FIGS. 10A-10F illustrate cross-sectional diagrams of exemplary transducers in accordance with other exemplary embodiments of the present invention;
  • [0018]
    FIG. 11 illustrates a schematic diagram of an acoustic coupling and cooling system in accordance with an exemplary embodiment of the present invention;
  • [0019]
    FIG. 12 illustrates a block diagram of an ultrasound treatment system combined with additional subsystems and methods of treatment monitoring and/or treatment imaging as well as a secondary treatment subsystem in accordance with an exemplary embodiment of the present invention; and
  • [0020]
    FIG. 13 illustrates a schematic diagram with imaging, therapy, or monitoring being provided with one or more active or passive oral inserts in accordance with an exemplary embodiment of the present invention.
  • DETAILED DESCRIPTION
  • [0021]
    The present invention may be described herein in terms of various components and processing steps. It should be appreciated that such components and steps may be realized by any number of hardware components configured to perform the specified functions. For example, the present invention may be configured with various medical treatment devices, visual imaging and display devices, input terminals and the like, which may carry out a variety of functions under the control of one or more control systems or other control devices. In addition, the present invention may be practiced in any number of medical or treatment contexts and that the exemplary embodiments relating to a method and system for sweat gland treatment as described herein are merely a few of the exemplary applications for the invention. For example, the principles, features and methods discussed may be applied to any medical or other tissue or treatment application.
  • [0022]
    In accordance with various aspects of the present invention, a non-invasive method and system for the treatment of sweat glands is described. In accordance with an exemplary embodiment, an ultrasound transducer probe and control system are configured to deliver ultrasound energy to a targeted/specified depth and zone where the sweat gland population is required to be treated. The ultrasound beam from the transducer probe can be spatially and/or temporally adjusted, modified or otherwise controlled to match the adequate treatment of the sweat glands in the region of interest.
  • [0023]
    For example, in accordance with an exemplary embodiment, with reference to FIG. 1, an exemplary treatment system 100 configured to treat a region of interest (ROI) 106 comprises a control system 102, an imaging/therapy probe with acoustic coupling 104, and a display system 108.
  • [0024]
    Control system 102 and display 108 can comprise various configurations for controlling functionality of probe 104 and system 100, including for example a microprocessor with software and a plurality of input/output and communication devices, a system for controlling electronic and/or mechanical scanning and/or multiplexing of transducers, a system for power delivery, systems for monitoring, systems for sensing the spatial parameters and/or temporal parameters of the probe and transducers, and/or systems for handling user input and recording treatment input and results, among others. Imaging/therapy probe 104 can comprise various probe and/or transducer configurations. For example, probe 104 can be configured for a combined dual-mode imaging/therapy transducer, coupled or co-housed imaging/therapy transducers, a separate therapy probe and separate imaging probe, or a single therapy probe. In accordance with exemplary embodiments, imaging transducers may operate at frequencies from approximately 2 MHz to 75 MHz or more, while therapy energy can be delivered at frequencies from approximately 500 kHz to 15 MHz, with 2 MHz to 25 MHz being typical.
  • [0025]
    With reference to FIG. 2A, sweat glands 230 are generally located within a dermis layer 214 at a depth close to hair bulbs 236. In order to treat sweat glands that require treatment in particular anatomical sites, such as, for example but not limited to, the axillary region (armpit), the palms and soles, an ultrasound transducer probe can be coupled to the skin tissue using one of the numerous coupling media, such as water, mineral oils, gels, and the like.
  • [0026]
    For example, with reference to FIG. 2B, in accordance with an exemplary embodiment an exemplary treatment method and system are configured for initially imaging a region 222 within a region of interest 206 and displaying that region 224 on a display 208 to facilitate localization of the treatment area and surrounding structures, e.g., identification of sweat glands 230, such as within the axillary region (armpit), the palms and soles or any other tissue or skin surrounding sweat glands. After localization, delivery of ultrasound energy 220 at a depth, distribution, timing, and energy level to achieve the desired therapeutic effect of thermal ablation to treat a sweat gland 230 is provided. Before, during, and/or after therapy, i.e., before, during and/or after delivery of ultrasound energy, monitoring of the treatment area and surrounding structures can be conducted to further planning and assessing of the results and/or providing feedback to control system 202 and a system operator.
  • [0027]
    In accordance with an exemplary embodiment, localization can be facilitated through ultrasound imaging that can be used to define the position of a sweat gland 230 and/or the depth of sweat glands 230 over a region of interest before depositing in a defined pattern at a target region 220. Such glands can be seen lying along hair follicles 232 and bulbs 236 and their image may be further enhanced via signal and image processing. Ultrasound imaging can also be used for safety purposes, namely, to avoid injuring vital structures, such as nerve endings 240. In accordance with other exemplary embodiments, localization can also be accomplished without imaging region 222, but instead can be based on prior known depths of sweat glands or other target regions, and thus be configured geometrically and/or electronically to selectively deposit energy at a particular known depth below skin surface 210 to a target region 220.
  • [0028]
    The ultrasound beam from probe 204 can be spatially and/or temporally controlled by changing the spatial parameters of the transducer, such as the placement, distance, treatment depth and transducer structure, as well as by changing the temporal parameters of transducer, such as the frequency, drive amplitude, and timing, with such control handled via control system 202. For example, in some applications, the temporal energy exposure at one location may range from approximately to 40 ms to 40 seconds, while the corresponding source frequency can suitably range from approximately 500 kHz to 15 MHz. Such spatial and temporal parameters can also be suitably monitored and/or utilized in open-loop and/or closed-loop feedback systems within treatment system 200. As a result of such spatial and/or temporal control, conformal lesions of various, specifically targeted, shapes, sizes and orientations can be configured within target region 220.
  • [0029]
    In accordance with an exemplary embodiment, the treatment resulting from ultrasound energy delivery in the region of sweat glands 230 can be used to achieve selective ablation of regions of sub-epidermal region (0.5-10 mm diameter zones). For example, one or more treated zones 242 can be configured to produce regions of ablative damage in spatially defined patterns, such as a discrete locus of spaced treatment spots or two- or three- dimensional matrix of damage or destroyed tissue, e.g., a matrix of cross-stitched, ellipsoidal/cigar-shaped, wedge-shaped, mushroom-shaped or any other conformal lesions, rather than heating and destroying the entire volume of the target layer of tissue. In such a treatment where surrounding regions are spared of damage, the surrounding undamaged tissue aids rapid healing and recovery.
  • [0030]
    In accordance with another exemplary embodiment, a whole contiguous sheet of treatment area can be achieved, whereby all the sweat glands within the said area are ablated. In addition to selective treatment of sweat gland regions, in accordance with another exemplary embodiment, treatment system 200 could be configured to “carpet bomb” the fat layer at 1-7 mm depth, e.g., up to 90% of the sweat glands in the armpit can be ablated without any physiologic issues.
  • [0031]
    In accordance with another exemplary embodiment of the present invention, an exemplary monitoring method may comprise monitoring the temperature profile or other tissue parameters of the region of interest 206, such as attenuation, speed of sound, or mechanical properties such as stiffness and strain of the treatment region and suitably adjust the spatial and/or temporal characteristics and energy levels of the ultrasound therapy transducer of probe 204. The results of such monitoring techniques may be indicated on display 208 by means of one-, two-, or three-dimensional images of monitoring results 250, or may simply comprise a success or fail-type indicator 252, or combinations thereof. Additional treatment monitoring techniques may be based on one or more of temperature, video, profilometry, and/or stiffness or strain gauges or any other suitable sensing technique.
  • [0032]
    The non-thermal effects from an acoustic field can also “shock” the sweat producing apocrine and eccrine cells in to reduced activity. These effects mentioned here as examples are, but not limited to, acoustic cavitation, acoustic streaming, inter-cellular shear effects, cell resonant effects, and the like.
  • [0033]
    In accordance with an exemplary embodiment, focused or directive ultrasound energy can be used for the treatment of sweat glands in the armpit (without the combination of pharmacological formulations). For example, a clinical indication would be to use in the management of Hidradenitis suppurativa. Ultrasound energy deposited at a selective depth can also be used in combination with a number of pharmaceutical formulations that are currently prescribed for the treatment of sweat gland hyperactivity in the axillary region, palms and soles. The ultrasound energy delivered to the target region in combination with the pharmaceutical agents such as BOTOX® or retinoids can help synergistically treat the sweat gland region by, (1) increasing activity of the agents due to the thermal and non-thermal mechanisms, (2) reduced requirement of overall drug dosage, as well as reducing the drug toxicity, (3) increase local effect of drug in a site selective manner.
  • [0034]
    An exemplary control system 202 and display system 208 may be configured in various manners for controlling probe and system functionality for providing the various exemplary treatment methods illustrated above. For example, with reference to FIGS. 3A and 3B, in accordance with exemplary embodiments, an exemplary control system 300 can be configured for coordination and control of the entire therapeutic treatment process to achieve the desired therapeutic effect of thermal ablation to treat a sweat gland. For example, control system 300 can suitably comprise power source components 302, sensing and monitoring components 304, cooling and coupling controls 306, and/or processing and control logic components 308. Control system 300 can be configured and optimized in a variety of ways with more or less subsystems and components to implement the therapeutic system for controlled thermal injury of sweat glands, and the embodiments in FIGS. 3A and 3B are merely for illustration purposes.
  • [0035]
    For example, for power sourcing components 302, control system 300 can comprise one or more direct current (DC) power supplies 303 configured to provide electrical energy for entire control system 300, including power required by a transducer electronic amplifier/driver 312. A DC current sense device 305 can also be provided to confirm the level of power going into amplifiers/drivers 312 for safety and monitoring purposes.
  • [0036]
    Amplifiers/drivers 312 can comprise multi-channel or single channel power amplifiers and/or drivers. In accordance with an exemplary embodiment for transducer array configurations, amplifiers/drivers 312 can also be configured with a beamformer to facilitate array focusing. An exemplary beamformer can be electrically excited by an oscillator/digitally controlled waveform synthesizer 310 with related switching logic.
  • [0037]
    The power sourcing components can also include various filtering configurations 314. For example, switchable harmonic filters and/or matching may be used at the output of amplifier/driver 312 to increase the drive efficiency and effectiveness. Power detection components 316 may also be included to confirm appropriate operation and calibration. For example, electric power and other energy detection components 316 may be used to monitor the amount of power going to an exemplary probe system.
  • [0038]
    Various sensing and monitoring components 304 may also be suitably implemented within control system 300. For example, in accordance with an exemplary embodiment, monitoring, sensing and interface control components 324 may be configured to operate with various motion detection systems implemented within transducer probe 204 to receive and process information such as acoustic or other spatial and temporal information from a region of interest. Sensing and monitoring components can also include various controls, interfacing and switches 309 and/or power detectors 316. Such sensing and monitoring components 304 can facilitate open-loop and/or closed-loop feedback systems within treatment system 200.
  • [0039]
    Cooling/coupling control systems 306 may be provided to remove waste heat from an exemplary probe 204, provide a controlled temperature at the superficial tissue interface and deeper into tissue, and/or provide acoustic coupling from transducer probe 204 to region-of-interest 206. Such cooling/coupling control systems 306 can also be configured to operate in both open-loop and/or closed-loop feedback arrangements with various coupling and feedback components.
  • [0040]
    Processing and control logic components 308 can comprise various system processors and digital control logic 307, such as one or more of microcontrollers, microprocessors, field-programmable gate arrays (FPGAs), computer boards, and associated components, including firmware and control software 326, which interfaces to user controls and interfacing circuits as well as input/output circuits and systems for communications, displays, interfacing, storage, documentation, and other useful functions. System software and firmware 326 controls all initialization, timing, level setting, monitoring, safety monitoring, and all other system functions required to accomplish user-defined treatment objectives. Further, various control switches 308 can also be suitably configured to control operation.
  • [0041]
    An exemplary transducer probe 204 can also be configured in various manners and comprise a number of reusable and/or disposable components and parts in various embodiments to facilitate its operation. For example, transducer probe 204 can be configured within any type of transducer probe housing or arrangement for facilitating the coupling of transducer to a tissue interface, with such housing comprising various shapes, contours and configurations. Transducer probe 204 can comprise any type of matching, such as for example, electric matching, which may be electrically switchable; multiplexer circuits and/or aperture/element selection circuits; and/or probe identification devices, to certify probe handle, electric matching, transducer usage history and calibration, such as one or more serial EEPROM (memories). Transducer probe 204 may also comprise cables and connectors; motion mechanisms, motion sensors and encoders; thermal monitoring sensors; and/or user control and status related switches, and indicators such as LEDs. For example, a motion mechanism in probe 204 may be used to controllably create multiple lesions, or sensing of probe motion itself may be used to controllably create multiple lesions and/or stop creation of lesions, e.g. for safety reasons if probe 204 is suddenly jerked or is dropped. In addition, an external motion encoder arm may be used to hold the probe during use, whereby the spatial position and attitude of probe 104 is sent to the control system to help controllably create lesions. Furthermore, other sensing functionality such as profilometers or other imaging modalities may be integrated into the probe in accordance with various exemplary embodiments.
  • [0042]
    With reference to FIGS. 4A and 4B, in accordance with an exemplary embodiment, a transducer probe 400 can comprise a control interface 402, a transducer 404, coupling components 406, and monitoring/sensing components 408, and/or motion mechanism 410. However, transducer probe 400 can be configured and optimized in a variety of ways with more or less parts and components to provide treatment of sweat glands, and the embodiments in FIGS. 4A and 4B are merely for illustration purposes.
  • [0043]
    Control interface 402 is configured for interfacing with control system 300 to facilitate control of transducer probe 400. Control interface components 402 can comprise multiplexer/aperture select 424, switchable electric matching networks 426, serial EEPROMs and/or other processing components and matching and probe usage information 430 and interface connectors 432.
  • [0044]
    Coupling components 406 can comprise various devices to facilitate coupling of transducer probe 400 to a region of interest. For example, coupling components 406 can comprise cooling and acoustic coupling system 420 configured for acoustic coupling of ultrasound energy and signals. Acoustic cooling/coupling system 420 with possible connections such as manifolds may be utilized to couple sound into the region-of-interest, control temperature at the interface and deeper into tissue, provide liquid-filled lens focusing, and/or to remove transducer waste heat. Coupling system 420 may facilitate such coupling through use of various coupling mediums, including air and other gases, water and other fluids, gels, solids, and/or any combination thereof, or any other medium that allows for signals to be transmitted between transducer active elements 412 and a region of interest. In addition to providing a coupling function, in accordance with an exemplary embodiment, coupling system 420 can also be configured for providing temperature control during the treatment application. For example, coupling system 420 can be configured for controlled cooling of an interface surface or region between transducer probe 400 and a region of interest and beyond by suitably controlling the temperature of the coupling medium. The suitable temperature for such coupling medium can be achieved in various manners, and utilize various feedback systems, such as thermocouples, thermistors or any other device or system configured for temperature measurement of a coupling medium. Such controlled cooling can be configured to further facilitate spatial and/or thermal energy control of transducer probe 400.
  • [0045]
    In accordance with an exemplary embodiment, with additional reference to FIG. 11, acoustic coupling and cooling 1140 can be provided to acoustically couple energy and imaging signals from transducer probe 1104 to and from the region of interest 1106 and deeper into tissue, to provide thermal control at the probe to region-of-interest interface 1110, and to remove potential waste heat from the transducer probe at region 1144. Temperature monitoring can be provided at the coupling interface via a thermal sensor 1146 to provide a mechanism of temperature measurement 1148 and control via control system 1102 and a thermal control system 1142. Thermal control may consist of passive cooling such as via heat sinks or natural conduction and convection or via active cooling such as with peltier thermoelectric coolers, refrigerants, or fluid-based systems comprised of pump, fluid reservoir, bubble detection, flow sensor, flow channels/tubing 1144 and thermal control 1142.
  • [0046]
    With continued reference to FIG. 4, monitoring and sensing components 408 can comprise various motion and/or position sensors 416, temperature monitoring sensors 418, user control and feedback switches 414 and other like components for facilitating control by control system 300, e.g., to facilitate spatial and/or temporal control through open-loop and closed-loop feedback arrangements that monitor various spatial and temporal characteristics.
  • [0047]
    Motion mechanism 410 can comprise manual operation, mechanical arrangements, or some combination thereof. For example, a motion mechanism 422 can be suitably controlled by control system 300, such as through the use of accelerometers, encoders or other position/orientation devices 416 to determine and enable movement and positions of transducer probe 400. Linear, rotational or variable movement can be facilitated, e.g., those depending on the treatment application and tissue contour surface.
  • [0048]
    Transducer 404 can comprise one or more transducers configured for treating of sweat glands and targeted regions. Transducer 404 can also comprise one or more transduction elements and/or lenses 412. The transduction elements can comprise a piezoelectrically active material, such as lead zirconante titanate (PZT), or any other piezoelectrically active material, such as a piezoelectric ceramic, crystal, plastic, and/or composite materials, as well as lithium niobate, lead titanate, barium titanate, and/or lead metaniobate. In addition to, or instead of, a piezoelectrically active material, transducer 404 can comprise any other materials configured for generating radiation and/or acoustical energy. Transducer 404 can also comprise one or more matching layers configured along with the transduction element such as coupled to the piezoelectrically active material. Acoustic matching layers and/or damping may be employed as necessary to achieve the desired electroacoustic response.
  • [0049]
    In accordance with an exemplary embodiment, the thickness of the transduction element of transducer 404 can be configured to be uniform. That is, a transduction element 412 can be configured to have a thickness that is substantially the same throughout. In accordance with another exemplary embodiment, the thickness of a transduction element 412 can also be configured to be variable. For example, transduction element(s) 412 of transducer 404 can be configured to have a first thickness selected to provide a center operating frequency of approximately 2 kHz to 75 MHz, such as for imaging applications. Transduction element 412 can also be configured with a second thickness selected to provide a center operating frequency of approximately 2 to 50 MHz, and typically between 2 MHz and 25 MHz for therapy application. Transducer 404 can be configured as a single broadband transducer excited with at least two or more frequencies to provide an adequate output for generating a desired response. Transducer 404 can also be configured as two or more individual transducers, wherein each transducer comprises one or more transduction element. The thickness of the transduction elements can be configured to provide center-operating frequencies in a desired treatment range.
  • [0050]
    Transducer 404 may be composed of one or more individual transducers in any combination of focused, planar, or unfocused single-element, multi-element, or array transducers, including 1-D, 2-D, and annular arrays; linear, curvilinear, sector, or spherical arrays; spherically, cylindrically, and/or electronically focused, defocused, and/or lensed sources. For example, with reference to an exemplary embodiment depicted in FIG. 5, transducer 500 can be configured as an acoustic array to facilitate phase focusing. That is, transducer 500 can be configured as an array of electronic apertures that may be operated by a variety of phases via variable electronic time delays. By the term “operated,” the electronic apertures of transducer 500 may be manipulated, driven, used, and/or configured to produce and/or deliver an energy beam corresponding to the phase variation caused by the electronic time delay. For example, these phase variations can be used to deliver defocused beams, planar beams, and/or focused beams, each of which may be used in combination to achieve different physiological effects in a region of interest 510. Transducer 500 may additionally comprise any software and/or other hardware for generating, producing and or driving a phased aperture array with one or more electronic time delays.
  • [0051]
    Transducer 500 can also be configured to provide focused treatment to one or more regions of interest using various frequencies. In order to provide focused treatment, transducer 500 can be configured with one or more variable depth devices to facilitate treatment. For example, transducer 500 may be configured with variable depth devices disclosed in U.S. patent application Ser. No. 10/944,500, entitled “System and Method for Variable Depth Ultrasound”, filed on Sep. 16, 2004, having at least one common inventor and a common Assignee as the present application, and incorporated herein by reference. In addition, transducer 500 can also be configured to treat one or more additional ROI 510 through the enabling of sub-harmonics or pulse-echo imaging, as disclosed in U.S. patent application Ser. No. 10/944,499, entitled “Method and System for Ultrasound Treatment with a Multi-directional Transducer”, filed on Sep. 16, 2004, having at least one common inventor and a common Assignee as the present application, and also incorporated herein by reference.
  • [0052]
    Moreover, any variety of mechanical lenses or variable focus lenses, e.g. liquid-filled lenses, may also be used to focus and or defocus the sound field. For example, with reference to exemplary embodiments depicted in FIGS. 6A and 6B, transducer 600 may also be configured with an electronic focusing array 604 in combination with one or more transduction elements 606 to facilitate increased flexibility in treating ROI 610. Array 604 may be configured in a manner similar to transducer 502. That is, array 604 can be configured as an array of electronic apertures that may be operated by a variety of phases via variable electronic time delays, for example, T1, T2 . . . Tj. By the term “operated,” the electronic apertures of array 604 may be manipulated, driven, used, and/or configured to produce and/or deliver energy in a manner corresponding to the phase variation caused by the electronic time delay. For example, these phase variations can be used to deliver defocused beams, planar beams, and/or focused beams, each of which may be used in combination to achieve different physiological effects in ROI 610.
  • [0053]
    Transduction elements 606 may be configured to be concave, convex, and/or planar. For example, in an exemplary embodiment depicted in FIG. 6A, transduction elements 606A are configured to be concave in order to provide focused energy for treatment of ROI 610. Additional embodiments are disclosed in U.S. patent application Ser. No. 10/944,500, entitled “Variable Depth Transducer System and Method”, and again incorporated herein by reference.
  • [0054]
    In another exemplary embodiment, depicted in FIG. 6B, transduction elements 606B can be configured to be substantially flat in order to provide substantially uniform energy to ROI 610. While FIGS. 6A and 6B depict exemplary embodiments with transduction elements 604 configured as concave and substantially flat, respectively, transduction elements 604 can be configured to be concave, convex, and/or substantially flat. In addition, transduction elements 604 can be configured to be any combination of concave, convex, and/or substantially flat structures. For example, a first transduction element can be configured to be concave, while a second transduction element can be configured to be substantially flat.
  • [0055]
    With reference to FIGS. 8A and 8B, transducer 404 can be configured as single-element arrays, wherein a single-element 802, e.g., a transduction element of various structures and materials, can be configured with a plurality of masks 804, such masks comprising ceramic, metal or any other material or structure for masking or altering energy distribution from element 802, creating an array of energy distributions 808. Masks 804 can be coupled directly to element 802 or separated by a standoff 806, such as any suitably solid or liquid material.
  • [0056]
    An exemplary transducer 404 can also be configured as an annular array to provide planar, focused and/or defocused acoustical energy. For example, with reference to FIGS. 10A and 10B, in accordance with an exemplary embodiment, an annular array 1000 can comprise a plurality of rings 1012, 1014, 1016 to N. Rings 1012, 1014, 1016 to N can be mechanically and electrically isolated into a set of individual elements, and can create planar, focused, or defocused waves. For example, such waves can be centered on-axis, such as by methods of adjusting corresponding transmit and/or receive delays, τ1, τ2, τ3 . . . τN. An electronic focus can be suitably moved along various depth positions, and can enable variable strength or beam tightness, while an electronic defocus can have varying amounts of defocusing. In accordance with an exemplary embodiment, a lens and/or convex or concave shaped annular array 1000 can also be provided to aid focusing or defocusing such that any time differential delays can be reduced. Movement of annular array 800 in one, two or three-dimensions, or along any path, such as through use of probes and/or any conventional robotic arm mechanisms, may be implemented to scan and/or treat a volume or any corresponding space within a region of interest.
  • [0057]
    Transducer 404 can also be configured in other annular or non-array configurations for imaging/therapy functions. For example, with reference to FIGS. 10C-10F, a transducer can comprise an imaging element 1012 configured with therapy element(s) 1014. Elements 1012 and 1014 can comprise a single-transduction element, e.g., a combined imaging/transducer element, or separate elements, can be electrically isolated 1022 within the same transduction element or between separate imaging and therapy elements, and/or can comprise standoff 1024 or other matching layers, or any combination thereof. For example, with particular reference to FIG. 10F, a transducer can comprise an imaging element 1012 having a surface 1028 configured for focusing, defocusing or planar energy distribution, with therapy elements 1014 including a stepped-configuration lens configured for focusing, defocusing, or planar energy distribution.
  • [0058]
    In accordance with various exemplary embodiments of the present invention, transducer 404 may be configured to provide one, two and/or three-dimensional treatment applications for focusing acoustic energy to one or more regions of interest. For example, as discussed above, transducer 404 can be suitably diced to form a one-dimensional array, e.g., transducer 602 comprising a single array of sub-transduction elements.
  • [0059]
    In accordance with another exemplary embodiment, transducer 404 may be suitably diced in two-dimensions to form a two-dimensional array. For example, with reference to FIG. 9, an exemplary two-dimensional array 900 can be suitably diced into a plurality of two-dimensional portions 902. Two-dimensional portions 902 can be suitably configured to focus on the treatment region at a certain depth, and thus provide respective slices 904 of the treatment region. As a result, the two-dimensional array 900 can provide a two-dimensional slicing of the image place of a treatment region, thus providing two-dimensional treatment.
  • [0060]
    In accordance with another exemplary embodiment, transducer 404 may be suitably configured to provide three-dimensional treatment. For example, to provide-three dimensional treatment of a region of interest, with reference again to FIG. 1, a three-dimensional system can comprise a transducer within probe 104 configured with an adaptive algorithm, such as, for example, one utilizing three-dimensional graphic software, contained in a control system, such as control system 102. The adaptive algorithm is suitably configured to receive two-dimensional imaging, temperature and/or treatment or other tissue parameter information relating to the region of interest, process the received information, and then provide corresponding three-dimensional imaging, temperature and/or treatment information.
  • [0061]
    In accordance with an exemplary embodiment, with reference again to FIG. 9, an exemplary three-dimensional system can comprise a two-dimensional array 900 configured with an adaptive algorithm to suitably receive 904 slices from different image planes of the treatment region, process the received information, and then provide volumetric information 906, e.g., three-dimensional imaging, temperature and/or treatment information. Moreover, after processing the received information with the adaptive algorithm, the two-dimensional array 900 may suitably provide therapeutic heating to the volumetric region 906 as desired.
  • [0062]
    In accordance with other exemplary embodiments, rather than utilizing an adaptive algorithm, such as three-dimensional software, to provide three-dimensional imaging and/or temperature information, an exemplary three-dimensional system can comprise a single transducer 404 configured within a probe arrangement to operate from various rotational and/or translational positions relative to a target region.
  • [0063]
    To further illustrate the various structures for transducer 404, with reference to FIG. 7, ultrasound therapy transducer 700 can be configured for a single focus, an array of foci, a locus of foci, a line focus, and/or diffraction patterns. Transducer 700 can also comprise single elements, multiple elements, annular arrays, one-, two-, or three-dimensional arrays, broadband transducers, and/or combinations thereof, with or without lenses, acoustic components, and mechanical and/or electronic focusing. Transducers configured as spherically focused single elements 702, annular arrays 704, annular arrays with damped regions 706, line focused single elements 708, 1-D linear arrays 710, 1-D curvilinear arrays in concave or convex form, with or without elevation focusing, 2-D arrays, and 3-D spatial arrangements of transducers may be used to perform therapy and/or imaging and acoustic monitoring functions. For any transducer configuration, focusing and/or defocusing may be in one plane or two planes via mechanical focus 720, convex lens 722, concave lens 724, compound or multiple lenses 726, planar form 728, or stepped form, such as illustrated in FIG. 10F. Any transducer or combination of transducers may be utilized for treatment. For example, an annular transducer may be used with an outer portion dedicated to therapy and the inner disk dedicated to broadband imaging wherein such imaging transducer and therapy transducer have different acoustic lenses and design, such as illustrated in FIG. 10C-10F.
  • [0064]
    Moreover, such transduction elements 700 may comprise a piezoelectrically active material, such as lead zirconante titanate (PZT), or any other piezoelectrically active material, such as a piezoelectric ceramic, crystal, plastic, and/or composite materials, as well as lithium niobate, lead titanate, barium titanate, and/or lead metaniobate. Transduction elements 700 may also comprise one or more matching layers configured along with the piezoelectrically active material. In addition to or instead of piezoelectrically active material, transduction elements 700 can comprise any other materials configured for generating radiation and/or acoustical energy. A means of transferring energy to and from the transducer to the region of interest is provided.
  • [0065]
    In accordance with another exemplary embodiment, with reference to FIG. 12, an exemplary treatment system 200 can be configured with and/or combined with various auxiliary systems to provide additional functions. For example, an exemplary treatment system 1200 for treatment of sweat glands can further comprise an auxiliary imaging modality 1272 and/or auxiliary monitoring modality 1274 may be based upon at least one of photography and other visual optical methods, magnetic resonance imaging (MRI), computed tomography (CT), optical coherence tomography (OCT), electromagnetic, microwave, or radio frequency (RF) methods, positron emission tomography (PET), infrared, ultrasound, acoustic, or any other suitable method of visualization, localization, or monitoring of the region-of-interest, including imaging/monitoring enhancements. Such imaging/monitoring enhancement for ultrasound imaging via probe 1204 and control system 1202 can comprise M-mode, persistence, filtering, color, Doppler, and harmonic imaging among others; furthermore an ultrasound treatment system 1270, as a primary source of treatment, may be combined with a secondary source of treatment 1276, including radio frequency (RF), intense pulsed light (IPL), laser, infrared laser, microwave, or any other suitable energy source.
  • [0066]
    In accordance with another exemplary embodiment, with reference to FIG. 13, treatment composed of imaging, monitoring, and/or therapy to a region of interest 1302 and/or 1308 may be aided, augmented, and/or delivered with passive or active devices 1304 and/or 1306 within the oral and/or nasal cavity, respectively. For example, if passive or active device 1304 and/or 1306 are second transducers or acoustic reflectors acoustically coupled to the mucous membranes it is possible to obtain through transmission, tomographic, or round-trip acoustic waves which are useful for treatment monitoring, such as in measuring acoustic speed of sound and attenuation, which are temperature dependent; furthermore such transducers could be used to treat and/or image. In addition an active, passive, or active/passive object 1304 and/or 1306 may be used to flatten the skin, and/or may be used as an imaging grid, marker, or beacon, to aid determination of position. A passive or active device 1304 and/or 1306 may also be used to aid cooling or temperature control. Natural air in the oral cavity and/or nasal cavity may also be used as passive device 1304 and/or 1306 whereby it may be utilized to as an acoustic reflector to aid thickness measurement and monitoring function.
  • [0067]
    The present invention may be described herein in terms of various functional components and processing steps. It should be appreciated that such components and steps may be realized by any number of hardware components configured to perform the specified functions. For example, the present invention may employ various medical treatment devices, visual imaging and display devices, input terminals and the like, which may carry out a variety of functions under the control of one or more control systems or other control devices. In addition, the present invention may be practiced in any number of medical contexts and that the exemplary embodiments relating to a system as described herein are merely indicative of exemplary applications for the invention. For example, the principles, features and methods discussed may be applied to any medical application. Further, various aspects of the present invention may be suitably applied to other applications, such as other medical or industrial applications.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3913386 *Jan 10, 1974Oct 21, 1975Commissariat Energie AtomiqueMethod of compensation for the angle of refraction of an ultrasonic beam and a device for the application of said method
US3965455 *Apr 25, 1974Jun 22, 1976The United States Of America As Represented By The Secretary Of The NavyFocused arc beam transducer-reflector
US3992925 *Dec 4, 1974Nov 23, 1976U.S. Philips CorporationDevice for ultrasonic scanning
US4039312 *Jan 15, 1975Aug 2, 1977Marcel Joseph Gaston PatruBacteriostatic, fungistatic and algicidal compositions, particularly for submarine paints
US4059098 *Jul 21, 1975Nov 22, 1977Stanford Research InstituteFlexible ultrasound coupling system
US4101795 *Jun 17, 1977Jul 18, 1978Matsushita Electric Industrial CompanyUltrasonic probe
US4213344 *Oct 16, 1978Jul 22, 1980Krautkramer-Branson, IncorporatedMethod and apparatus for providing dynamic focussing and beam steering in an ultrasonic apparatus
US4276491 *Oct 2, 1979Jun 30, 1981Ausonics Pty. LimitedFocusing piezoelectric ultrasonic medical diagnostic system
US4315514 *May 8, 1980Feb 16, 1982William DrewesMethod and apparatus for selective cell destruction
US4325381 *Nov 21, 1979Apr 20, 1982New York Institute Of TechnologyUltrasonic scanning head with reduced geometrical distortion
US4343301 *Oct 4, 1979Aug 10, 1982Robert IndechSubcutaneous neural stimulation or local tissue destruction
US4381007 *Apr 30, 1981Apr 26, 1983The United States Of America As Represented By The United States Department Of EnergyMultipolar corneal-shaping electrode with flexible removable skirt
US4381787 *Aug 15, 1980May 3, 1983Technicare CorporationUltrasound imaging system combining static B-scan and real-time sector scanning capability
US4397314 *Aug 3, 1981Aug 9, 1983Clini-Therm CorporationMethod and apparatus for controlling and optimizing the heating pattern for a hyperthermia system
US4409839 *Jul 1, 1981Oct 18, 1983Siemens AgUltrasound camera
US4441486 *Oct 27, 1981Apr 10, 1984Board Of Trustees Of Leland Stanford Jr. UniversityHyperthermia system
US4452084 *Oct 25, 1982Jun 5, 1984Sri InternationalInherent delay line ultrasonic transducer and systems
US4484569 *Mar 1, 1982Nov 27, 1984Riverside Research InstituteUltrasonic diagnostic and therapeutic transducer assembly and method for using
US4513749 *Nov 18, 1982Apr 30, 1985Board Of Trustees Of Leland Stanford UniversityThree-dimensional temperature probe
US4527550 *Jan 28, 1983Jul 9, 1985The United States Of America As Represented By The Department Of Health And Human ServicesHelical coil for diathermy apparatus
US4528979 *Mar 18, 1982Jul 16, 1985Kievsky Nauchno-Issledovatelsky Institut Otolaringologii Imeni Professora A.S. KolomiiobenkaCryo-ultrasonic surgical instrument
US4567895 *Apr 2, 1984Feb 4, 1986Advanced Technology Laboratories, Inc.Fully wetted mechanical ultrasound scanhead
US4586512 *Mar 27, 1985May 6, 1986Thomson-CsfDevice for localized heating of biological tissues
US4601296 *Oct 7, 1983Jul 22, 1986Yeda Research And Development Co., Ltd.Hyperthermia apparatus
US4646756 *Oct 24, 1983Mar 3, 1987The University Of AberdeenUltra sound hyperthermia device
US4663358 *Apr 25, 1986May 5, 1987Biomaterials Universe, Inc.Porous and transparent poly(vinyl alcohol) gel and method of manufacturing the same
US4668516 *Mar 23, 1984May 26, 1987Alain DuraffourdComposition for regenerating the collagen of connective skin tissue and a process for its preparation
US4697588 *Dec 11, 1985Oct 6, 1987Siemens AktiengesellschaftShock wave tube for the fragmentation of concrements
US4757820 *Mar 12, 1986Jul 19, 1988Kabushiki Kaisha ToshibaUltrasound therapy system
US4807633 *May 21, 1986Feb 28, 1989Indianapolis Center For Advanced ResearchNon-invasive tissue thermometry system and method
US4858613 *Mar 2, 1988Aug 22, 1989Laboratory Equipment, Corp.Localization and therapy system for treatment of spatially oriented focal disease
US4860732 *Nov 23, 1988Aug 29, 1989Olympus Optical Co., Ltd.Endoscope apparatus provided with endoscope insertion aid
US4865041 *Feb 1, 1988Sep 12, 1989Siemens AktiengesellschaftLithotripter having an ultrasound locating system integrated therewith
US4865042 *Aug 8, 1986Sep 12, 1989Hitachi, Ltd.Ultrasonic irradiation system
US4867169 *Jul 7, 1987Sep 19, 1989Kaoru MachidaAttachment attached to ultrasound probe for clinical application
US4874562 *Feb 9, 1987Oct 17, 1989Biomaterials Universe, Inc.Method of molding a polyvinyl alcohol contact lens
US4875487 *May 2, 1986Oct 24, 1989Varian Associates, Inc.Compressional wave hyperthermia treating method and apparatus
US4893624 *Jun 21, 1988Jan 16, 1990Massachusetts Institute Of TechnologyDiffuse focus ultrasound hyperthermia system
US4917096 *Nov 25, 1987Apr 17, 1990Laboratory Equipment, Corp.Portable ultrasonic probe
US4938216 *Jun 21, 1988Jul 3, 1990Massachusetts Institute Of TechnologyMechanically scanned line-focus ultrasound hyperthermia system
US4938217 *Jun 21, 1988Jul 3, 1990Massachusetts Institute Of TechnologyElectronically-controlled variable focus ultrasound hyperthermia system
US4947046 *May 25, 1989Aug 7, 1990Konica CorporationMethod for preparation of radiographic image conversion panel and radiographic image conversion panel thereby
US4951653 *Mar 2, 1988Aug 28, 1990Laboratory Equipment, Corp.Ultrasound brain lesioning system
US4955365 *Jun 22, 1989Sep 11, 1990Laboratory Equipment, Corp.Localization and therapy system for treatment of spatially oriented focal disease
US4958626 *Feb 29, 1988Sep 25, 1990Nippon Oil Co., Ltd.Method for applying electromagnetic wave and ultrasonic wave therapies
US4973096 *Aug 21, 1989Nov 27, 1990Joyce Patrick HShoe transporting device
US4976709 *Jun 30, 1989Dec 11, 1990Sand Bruce JMethod for collagen treatment
US4979501 *May 18, 1988Dec 25, 1990Vissh Voennomedicinski InstitutMethod and apparatus for medical treatment of the pathological state of bones
US5012797 *Jan 8, 1990May 7, 1991Montefiore Hospital Association Of Western PennsylvaniaMethod for removing skin wrinkles
US5036855 *Jun 22, 1989Aug 6, 1991Laboratory Equipment, Corp.Localization and therapy system for treatment of spatially oriented focal disease
US5054470 *Dec 5, 1989Oct 8, 1991Laboratory Equipment, Corp.Ultrasonic treatment transducer with pressurized acoustic coupling
US5115814 *Aug 18, 1989May 26, 1992Intertherapy, Inc.Intravascular ultrasonic imaging probe and methods of using same
US5117832 *Aug 20, 1991Jun 2, 1992Diasonics, Inc.Curved rectangular/elliptical transducer
US5123418 *Feb 27, 1990Jun 23, 1992Centre National De La Recherche Scientifique-C.N.R.SMicro-echographic probe for ultrasound collimation through a deformable surface
US5143063 *Feb 9, 1988Sep 1, 1992Fellner Donald GMethod of removing adipose tissue from the body
US5143074 *May 3, 1991Sep 1, 1992Edap InternationalUltrasonic treatment device using a focussing and oscillating piezoelectric element
US5150711 *Jul 23, 1991Sep 29, 1992Edap International, S.A.Ultra-high-speed extracorporeal ultrasound hyperthermia treatment device
US5150714 *May 10, 1991Sep 29, 1992Sri InternationalUltrasonic inspection method and apparatus with audible output
US5156144 *Aug 28, 1990Oct 20, 1992Olympus Optical Co., Ltd.Ultrasonic wave therapeutic device
US5158536 *Mar 19, 1990Oct 27, 1992Biopulmonics, Inc.Lung cancer hyperthermia via ultrasound and/or convection with perfiuorochemical liquids
US5163421 *Dec 12, 1989Nov 17, 1992Angiosonics, Inc.In vivo ultrasonic system with angioplasty and ultrasonic contrast imaging
US5191880 *Apr 13, 1992Mar 9, 1993Mcleod Kenneth JMethod for the promotion of growth, ingrowth and healing of bone tissue and the prevention of osteopenia by mechanical loading of the bone tissue
US5209720 *Jun 18, 1991May 11, 1993Unger Evan CMethods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes
US5224467 *Oct 23, 1992Jul 6, 1993Kabushiki Kaisha Machida SeisakushoEndoscope with direction indication mechanism
US5230334 *Jan 22, 1992Jul 27, 1993Summit Technology, Inc.Method and apparatus for generating localized hyperthermia
US5230338 *Apr 22, 1992Jul 27, 1993Allen George SInteractive image-guided surgical system for displaying images corresponding to the placement of a surgical tool or the like
US5265614 *Aug 29, 1989Nov 30, 1993Fujitsu LimitedAcoustic coupler
US5267985 *Feb 11, 1993Dec 7, 1993Trancell, Inc.Drug delivery by multiple frequency phonophoresis
US5269297 *Feb 27, 1992Dec 14, 1993Angiosonics Inc.Ultrasonic transmission apparatus
US5282797 *May 28, 1991Feb 1, 1994Cyrus ChessMethod for treating cutaneous vascular lesions
US5295484 *May 19, 1992Mar 22, 1994Arizona Board Of Regents For And On Behalf Of The University Of ArizonaApparatus and method for intra-cardiac ablation of arrhythmias
US5304169 *Aug 17, 1992Apr 19, 1994Laser Biotech, Inc.Method for collagen shrinkage
US5321520 *Jul 20, 1992Jun 14, 1994Automated Medical Access CorporationAutomated high definition/resolution image storage, retrieval and transmission system
US5360268 *Nov 1, 1993Nov 1, 1994Nippon Soken Inc.Ultrasonic temperature measuring apparatus
US5370121 *Sep 3, 1993Dec 6, 1994Siemens AktiengesellschaftMethod and apparatus for non-invasive measurement of a temperature change in a subject
US5371483 *Dec 20, 1993Dec 6, 1994Bhardwaj; Mahesh C.High intensity guided ultrasound source
US5380280 *Nov 12, 1993Jan 10, 1995Peterson; Erik W.Aspiration system having pressure-controlled and flow-controlled modes
US5419327 *Nov 19, 1993May 30, 1995Siemens AktiengesellschaftAcoustic therapy means
US5435311 *May 16, 1994Jul 25, 1995Hitachi, Ltd.Ultrasound therapeutic system
US5458596 *May 6, 1994Oct 17, 1995Dorsal Orthopedic CorporationMethod and apparatus for controlled contraction of soft tissue
US5460595 *Jun 1, 1993Oct 24, 1995Dynatronics Laser CorporationMulti-frequency ultrasound therapy systems and methods
US5471488 *Apr 5, 1994Nov 28, 1995International Business Machines CorporationClock fault detection circuit
US5487388 *Nov 1, 1994Jan 30, 1996Interspec. Inc.Three dimensional ultrasonic scanning devices and techniques
US5492126 *May 2, 1994Feb 20, 1996Focal SurgeryProbe for medical imaging and therapy using ultrasound
US5496256 *Jun 9, 1994Mar 5, 1996Sonex International CorporationUltrasonic bone healing device for dental application
US5501655 *Jul 15, 1994Mar 26, 1996Massachusetts Institute Of TechnologyApparatus and method for acoustic heat generation and hyperthermia
US5503320 *Aug 19, 1993Apr 2, 1996United States Surgical CorporationSurgical apparatus with indicator
US5507790 *Mar 21, 1994Apr 16, 1996Weiss; William V.Method of non-invasive reduction of human site-specific subcutaneous fat tissue deposits by accelerated lipolysis metabolism
US5520188 *Nov 2, 1994May 28, 1996Focus Surgery Inc.Annular array transducer
US5522869 *Mar 8, 1995Jun 4, 1996Burdette; Everette C.Ultrasound device for use in a thermotherapy apparatus
US5524620 *Jan 26, 1994Jun 11, 1996November Technologies Ltd.Ablation of blood thrombi by means of acoustic energy
US5524624 *May 5, 1994Jun 11, 1996Amei Technologies Inc.Apparatus and method for stimulating tissue growth with ultrasound
US5526812 *Oct 27, 1995Jun 18, 1996General Electric CompanyDisplay system for enhancing visualization of body structures during medical procedures
US6315741 *Sep 3, 1999Nov 13, 2001Roy W. MartinMethod and apparatus for medical procedures using high-intensity focused ultrasound
US6413254 *Jan 19, 2000Jul 2, 2002Medtronic Xomed, Inc.Method of tongue reduction by thermal ablation using high intensity focused ultrasound
US6623430 *Feb 10, 2000Sep 23, 2003Guided Therapy Systems, Inc.Method and apparatus for safety delivering medicants to a region of tissue using imaging, therapy and temperature monitoring ultrasonic system
US20030176790 *Feb 4, 2003Sep 18, 2003Guided Therapy Systems, Inc.Visual imaging system for ultrasonic probe
US20040267252 *Jun 30, 2003Dec 30, 2004Ethicon, Inc.Multi-modality ablation device
US20050154332 *Jan 12, 2004Jul 14, 2005OndaMethods and systems for removing hair using focused acoustic energy
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7491171Oct 7, 2005Feb 17, 2009Guided Therapy Systems, L.L.C.Method and system for treating acne and sebaceous glands
US7758524Oct 6, 2005Jul 20, 2010Guided Therapy Systems, L.L.C.Method and system for ultra-high frequency ultrasound treatment
US7824348Nov 2, 2010Guided Therapy Systems, L.L.C.System and method for variable depth ultrasound treatment
US8066641Oct 6, 2005Nov 29, 2011Guided Therapy Systems, L.L.C.Method and system for treating photoaged tissue
US8073550Aug 14, 2000Dec 6, 2011Miramar Labs, Inc.Method and apparatus for treating subcutaneous histological features
US8133180Oct 6, 2005Mar 13, 2012Guided Therapy Systems, L.L.C.Method and system for treating cellulite
US8166332Jul 24, 2009Apr 24, 2012Ardent Sound, Inc.Treatment system for enhancing safety of computer peripheral for use with medical devices by isolating host AC power
US8235909Aug 7, 2012Guided Therapy Systems, L.L.C.Method and system for controlled scanning, imaging and/or therapy
US8282554Oct 9, 2012Guided Therapy Systems, LlcMethods for treatment of sweat glands
US8333700Sep 4, 2012Dec 18, 2012Guided Therapy Systems, L.L.C.Methods for treatment of hyperhidrosis
US8366622Apr 11, 2012Feb 5, 2013Guided Therapy Systems, LlcTreatment of sub-dermal regions for cosmetic effects
US8401668Sep 27, 2011Mar 19, 2013Miramar Labs, Inc.Systems and methods for creating an effect using microwave energy to specified tissue
US8406894Mar 26, 2013Miramar Labs, Inc.Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
US8409097Apr 2, 2013Ardent Sound, IncVisual imaging system for ultrasonic probe
US8439940Dec 22, 2010May 14, 2013Cabochon Aesthetics, Inc.Dissection handpiece with aspiration means for reducing the appearance of cellulite
US8444562Jun 12, 2012May 21, 2013Guided Therapy Systems, LlcSystem and method for treating muscle, tendon, ligament and cartilage tissue
US8460193Jun 3, 2010Jun 11, 2013Guided Therapy Systems LlcSystem and method for ultra-high frequency ultrasound treatment
US8469951Nov 15, 2012Jun 25, 2013Miramar Labs, Inc.Applicator and tissue interface module for dermatological device
US8480585May 4, 2007Jul 9, 2013Guided Therapy Systems, LlcImaging, therapy and temperature monitoring ultrasonic system and method
US8506486Nov 16, 2012Aug 13, 2013Guided Therapy Systems, LlcUltrasound treatment of sub-dermal tissue for cosmetic effects
US8523775Sep 4, 2012Sep 3, 2013Guided Therapy Systems, LlcEnergy based hyperhidrosis treatment
US8535228Feb 8, 2008Sep 17, 2013Guided Therapy Systems, LlcMethod and system for noninvasive face lifts and deep tissue tightening
US8535302Nov 15, 2012Sep 17, 2013Miramar Labs, Inc.Applicator and tissue interface module for dermatological device
US8574251Feb 21, 2013Nov 5, 2013Cabochon Aesthetics, Inc.Dissection handpiece and method for reducing the appearance of cellulite
US8636665Mar 7, 2013Jan 28, 2014Guided Therapy Systems, LlcMethod and system for ultrasound treatment of fat
US8641622Sep 12, 2011Feb 4, 2014Guided Therapy Systems, LlcMethod and system for treating photoaged tissue
US8663112Dec 23, 2009Mar 4, 2014Guided Therapy Systems, LlcMethods and systems for fat reduction and/or cellulite treatment
US8672848Jan 23, 2012Mar 18, 2014Guided Therapy Systems, LlcMethod and system for treating cellulite
US8688228Dec 12, 2008Apr 1, 2014Miramar Labs, Inc.Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
US8690778Jun 21, 2013Apr 8, 2014Guided Therapy Systems, LlcEnergy-based tissue tightening
US8690779Jun 21, 2013Apr 8, 2014Guided Therapy Systems, LlcNoninvasive aesthetic treatment for tightening tissue
US8690780Jun 21, 2013Apr 8, 2014Guided Therapy Systems, LlcNoninvasive tissue tightening for cosmetic effects
US8708935Jul 12, 2010Apr 29, 2014Guided Therapy Systems, LlcSystem and method for variable depth ultrasound treatment
US8715186Nov 24, 2010May 6, 2014Guided Therapy Systems, LlcMethods and systems for generating thermal bubbles for improved ultrasound imaging and therapy
US8753339Feb 21, 2013Jun 17, 2014Ulthera, Inc.Dissection handpiece and method for reducing the appearance of cellulite
US8764687May 7, 2008Jul 1, 2014Guided Therapy Systems, LlcMethods and systems for coupling and focusing acoustic energy using a coupler member
US8825176Feb 20, 2013Sep 2, 2014Miramar Labs, Inc.Apparatus for the noninvasive treatment of tissue using microwave energy
US8852103Oct 17, 2012Oct 7, 2014Butterfly Network, Inc.Transmissive imaging and related apparatus and methods
US8853600Nov 9, 2012Oct 7, 2014Miramar Labs, Inc.Method and apparatus for treating subcutaneous histological features
US8857438Nov 8, 2011Oct 14, 2014Ulthera, Inc.Devices and methods for acoustic shielding
US8858471Jul 10, 2012Oct 14, 2014Guided Therapy Systems, LlcMethods and systems for ultrasound treatment
US8868958Apr 23, 2012Oct 21, 2014Ardent Sound, IncMethod and system for enhancing computer peripheral safety
US8894678May 29, 2014Nov 25, 2014Ulthera, Inc.Cellulite treatment methods
US8900261May 29, 2014Dec 2, 2014Ulthera, Inc.Tissue treatment system for reducing the appearance of cellulite
US8900262May 29, 2014Dec 2, 2014Ulthera, Inc.Device for dissection of subcutaneous tissue
US8906054May 29, 2014Dec 9, 2014Ulthera, Inc.Apparatus for reducing the appearance of cellulite
US8915853Mar 15, 2013Dec 23, 2014Guided Therapy Systems, LlcMethods for face and neck lifts
US8915854Jan 27, 2014Dec 23, 2014Guided Therapy Systems, LlcMethod for fat and cellulite reduction
US8915870Oct 6, 2009Dec 23, 2014Guided Therapy Systems, LlcMethod and system for treating stretch marks
US8920324Feb 27, 2014Dec 30, 2014Guided Therapy Systems, LlcEnergy based fat reduction
US8920452May 29, 2014Dec 30, 2014Ulthera, Inc.Methods of tissue release to reduce the appearance of cellulite
US8932224Jul 25, 2013Jan 13, 2015Guided Therapy Systems, LlcEnergy based hyperhidrosis treatment
US8979881May 29, 2014Mar 17, 2015Ulthera, Inc.Methods and handpiece for use in tissue dissection
US9005229Dec 12, 2012Apr 14, 2015Ulthera, Inc.Dissection handpiece and method for reducing the appearance of cellulite
US9011336May 7, 2008Apr 21, 2015Guided Therapy Systems, LlcMethod and system for combined energy therapy profile
US9011337Jul 11, 2012Apr 21, 2015Guided Therapy Systems, LlcSystems and methods for monitoring and controlling ultrasound power output and stability
US9011473Dec 12, 2012Apr 21, 2015Ulthera, Inc.Dissection handpiece and method for reducing the appearance of cellulite
US9022936Feb 27, 2014May 5, 2015Butterfly Network, Inc.Transmissive imaging and related apparatus and methods
US9028412Feb 27, 2014May 12, 2015Butterfly Network, Inc.Transmissive imaging and related apparatus and methods
US9028477Sep 3, 2013May 12, 2015Miramar Labs, Inc.Applicator and tissue interface module for dermatological device
US9033884Feb 27, 2014May 19, 2015Butterfly Network, Inc.Transmissive imaging and related apparatus and methods
US9039617May 6, 2014May 26, 2015Guided Therapy Systems, LlcMethods and systems for generating thermal bubbles for improved ultrasound imaging and therapy
US9039619Jan 31, 2014May 26, 2015Guided Therapy Systems, L.L.C.Methods for treating skin laxity
US9039722Feb 27, 2013May 26, 2015Ulthera, Inc.Dissection handpiece with aspiration means for reducing the appearance of cellulite
US9044259Dec 22, 2014Jun 2, 2015Ulthera, Inc.Methods for dissection of subcutaneous tissue
US9078688Dec 22, 2014Jul 14, 2015Ulthera, Inc.Handpiece for use in tissue dissection
US9095697Aug 13, 2013Aug 4, 2015Guided Therapy Systems, LlcMethods for preheating tissue for cosmetic treatment of the face and body
US9114247Nov 10, 2011Aug 25, 2015Guided Therapy Systems, LlcMethod and system for ultrasound treatment with a multi-directional transducer
US9149255Feb 27, 2014Oct 6, 2015Butterfly Network, Inc.Image-guided high intensity focused ultrasound and related apparatus and methods
US9149331 *Apr 18, 2008Oct 6, 2015Miramar Labs, Inc.Methods and apparatus for reducing sweat production
US9149658Aug 2, 2011Oct 6, 2015Guided Therapy Systems, LlcSystems and methods for ultrasound treatment
US9155521Feb 27, 2014Oct 13, 2015Butterfly Network, Inc.Transmissive imaging and related apparatus and methods
US9198637Feb 27, 2014Dec 1, 2015Butterfly Network, Inc.Transmissive imaging and related apparatus and methods
US9216276May 7, 2008Dec 22, 2015Guided Therapy Systems, LlcMethods and systems for modulating medicants using acoustic energy
US9241683Oct 4, 2006Jan 26, 2016Ardent Sound Inc.Ultrasound system and method for imaging and/or measuring displacement of moving tissue and fluid
US9241763Apr 17, 2009Jan 26, 2016Miramar Labs, Inc.Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
US9247924Feb 27, 2014Feb 2, 2016Butterfly Networks, Inc.Transmissive imaging and related apparatus and methods
US9248317Jun 29, 2007Feb 2, 2016Ulthera, Inc.Devices and methods for selectively lysing cells
US9263663Apr 15, 2013Feb 16, 2016Ardent Sound, Inc.Method of making thick film transducer arrays
US9268014Feb 27, 2014Feb 23, 2016Butterfly Network, Inc.Transmissive imaging and related apparatus and methods
US9268015Feb 27, 2014Feb 23, 2016Butterfly Network, Inc.Image-guided high intensity focused ultrasound and related apparatus and methods
US9272124Nov 7, 2014Mar 1, 2016Ulthera, Inc.Systems and devices for selective cell lysis and methods of using same
US9272162Jul 8, 2013Mar 1, 2016Guided Therapy Systems, LlcImaging, therapy, and temperature monitoring ultrasonic method
US9283409Nov 21, 2014Mar 15, 2016Guided Therapy Systems, LlcEnergy based fat reduction
US9283410Nov 21, 2014Mar 15, 2016Guided Therapy Systems, L.L.C.System and method for fat and cellulite reduction
US9314301Jul 31, 2012Apr 19, 2016Miramar Labs, Inc.Applicator and tissue interface module for dermatological device
US9320537Aug 12, 2013Apr 26, 2016Guided Therapy Systems, LlcMethods for noninvasive skin tightening
US20060089632 *Oct 7, 2005Apr 27, 2006Guided Therapy Systems, L.L.C.Method and system for treating acne and sebaceous glands
US20070213705 *Mar 7, 2007Sep 13, 2007Schmid Peter MInsulated needle and system
US20080021353 *Jan 3, 2007Jan 24, 2008Manfred MenziAcoustic pressure wave applicator system with conduction pad
US20080139974 *Nov 29, 2007Jun 12, 2008Da Silva Luiz BDevices and Methods for Treatment of Skin Conditions
US20090062724 *Aug 31, 2007Mar 5, 2009Rixen ChenSystem and apparatus for sonodynamic therapy
US20090093737 *Oct 8, 2008Apr 9, 2009Cabochon Aesthetics, Inc.Ultrasound apparatus with treatment lens
US20100049178 *Apr 18, 2008Feb 25, 2010Deem Mark EMethods and apparatus for reducing sweat production
US20100222852 *Sep 2, 2010Vasily David BApparatus and Method for Decolonizing Microbes on the Surfaces of the Skin and In Body Cavities
US20110196365 *Oct 22, 2009Aug 11, 2011Miramar Labs, Inc.Systems, Apparatus, Methods, and Procedures for the Non-Invasive Treatment of Tissue Using Microwave Energy
US20110201976 *Aug 18, 2011Focus Surgery, Inc.Laparoscopic hifu probe
US20120165668 *Jun 28, 2012Guided Therapy Systems, LlcSystems and methods for treating acute and/or chronic injuries in soft tissue
US20130123625 *Nov 14, 2012May 16, 2013Boston Scientific Scimed, Inc.Integrated ultrasound ablation and imaging device and related methods
DE102012209008A1 *May 29, 2012Dec 5, 2013Wellcomet GmbhDevice for generation of e.g. radio frequency current for pressurization of human tissue with frequency current, has motion sensor cooperating with control unit such that intensity of wave is controlled depending on measurement signals
DE102012209008B4 *May 29, 2012Feb 5, 2015Wellcomet GmbhVorrichtung zum Erzeugen von Behandlungswellen
EP2532320A2Apr 18, 2008Dec 12, 2012Miramar Labs, Inc.Apparatus for reducing sweat production
WO2008131302A2 *Apr 18, 2008Oct 30, 2008The Foundry, Inc.Methods and apparatus for reducing sweat production
WO2008131302A3 *Apr 18, 2008Dec 30, 2009The Foundry, Inc.Methods and apparatus for reducing sweat production
Classifications
U.S. Classification607/1
International ClassificationA61N1/39
Cooperative ClassificationA61B8/4281, A61N2007/0078, A61N7/02, A61N7/00, A61B2018/00005, A61B17/320068
European ClassificationA61N7/02
Legal Events
DateCodeEventDescription
Dec 29, 2005ASAssignment
Owner name: GUIDED THERAPY SYSTEMS, L.L.C., ARIZONA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MAKIN, INDER RAJ S.;BARTHE, PETER B.;SLAYTON, MICHAEL H.;REEL/FRAME:016952/0721;SIGNING DATES FROM 20051201 TO 20051216